27.06.2013 Views

Voie d'immunisation et séquence d'administration de l ... - TEL

Voie d'immunisation et séquence d'administration de l ... - TEL

Voie d'immunisation et séquence d'administration de l ... - TEL

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

tel-00827710, version 1 - 29 May 2013<br />

the Ova-specific T cells were producing IFNγ after i.v. injection; whereas 50-70% of the cells<br />

were effector CD8 + T cells at the peak of the i.d. response (Figure 24B). Representative<br />

FACS plots highlight that not only did we achieve a higher percentage of IFNγ-producing<br />

cells with i.d. injection, but also, on a per cell basis, many of the effector T cells were making<br />

10-fold more cytokine as compared to those isolated after i.v. immunization (Figure 24C).<br />

This was also evi<strong>de</strong>nt using a population-based analysis – as shown, the geom<strong>et</strong>ric mean<br />

fluorescent intensity (MFI) of t<strong>et</strong>ramer-positive cells was significantly higher in the i.d.<br />

condition on days 9-15 (Figure 24D). While intra<strong>de</strong>rmal immunization is <strong>de</strong>layed, it cross-<br />

primes CD8 + T cells with greater effector function.<br />

Page 95 of 256

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!